No Data
No Data
Paradigm Biopharmaceuticals to Raise AU$16 Million via Share Placement; Shares Down 6%
Why ANZ, Calix, Paradigm, and Platinum Shares Are Tumbling Today
Paradigm Biopharma Highlights Investment Risks and Cautions
Paradigm Biopharmaceuticals Secures $16M for Global Trials
Why Is This ASX Healthcare Stock Crashing 26% Today?
This ASX Healthcare Stock Is up 160% in a Month! Here's Why It's Just Entered a Trading Halt
No Data